News
Actinium Announces KOL Webinar To Highlight Recently Announced Iomab-ACT Trial With Leading FDA Approved Commercial CAR T-Cell Therapy Being Led By The University Of Texas Southwestern
7 May 24
Biotech, News, General
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $50 Price Target
2 May 24
News, Price Target, Reiteration, Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Actinium Pharma, Maintains $21 Price Target
30 Apr 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $50 Price Target
29 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Actinium Highlights Ability Of Iomab-B To Overcome High-Risk TP53 Mutation Resulting In Improvement In Overall Survival In Patients With Active Relapsed Refractory AML At The European Bone Marrow Transplant Annual Meeting
18 Apr 24
Biotech, News, General
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $50 Price Target
1 Apr 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $50 Price Target
26 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Actinium Announces Clinical Trial to Study Iomab-ACT Targeted Radiotherapy Conditioning with Leading FDA Approved Commercial CAR T-Cell Therapy
26 Mar 24
News
Maxim Group Maintains Buy on Actinium Pharma, Raises Price Target to $30
19 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Actinium Pharma, Maintains $50 Price Target
19 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Actinium Pharma, Maintains $50 Price Target
11 Mar 24
News, Price Target, Analyst Ratings
12 Health Care Stocks Moving In Friday's After-Market Session
9 Feb 24
Movers
Press releases
Actinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions
8 May 24
News, Press Releases
Investment Opportunities in Biotech Amidst Federal Rate Uncertainties (ATNM)
22 Apr 24
News, Press Releases
Actinium Pharmaceuticals (ATNM) Leads Biotech Innovation Amid Economic Uncertainty
19 Apr 24
News, Press Releases
Actinium Highlights Ability of Iomab-B to Overcome High-Risk TP53 Mutation Resulting in Significant Improvement in Overall Survival in Patients with Active Relapsed Refractory AML at the European Bone Marrow Transplant Annual Meeting
18 Apr 24
Press Releases
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
18 Apr 24
News, Press Releases
Actinium Pharmaceuticals (ATNM) Garners Attention with Clinical Successes and Strategic Market Moves Amid Growing Radiopharma Interest
17 Apr 24
News, Press Releases
Revolutionizing Targeted Cancer Treatment and Radiotherapy Manufacturing: Actinium Pharmaceuticals (NYSE: ATNM) Trailblazing Journey
28 Mar 24
News, Press Releases
Actinium Pharmaceuticals (ATNM) Spearheading the Future of Oncology with Iomab-ACT's Innovative Clinical Trial
27 Mar 24
News, Press Releases
Actinium Announces Clinical Trial to Study Iomab-ACT Targeted Radiotherapy Conditioning with Leading FDA Approved Commercial CAR T-Cell Therapy
26 Mar 24
Press Releases
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma Acquisition Wave
26 Mar 24
News, Press Releases
FDA Approves Vertex Pharmaceuticals (NASDAQ:VRTX) VX-407 for Phase I Study in Groundbreaking Move Against Polycystic Kidney Disease"
25 Mar 24
News, Press Releases
Actinium Pharmaceuticals Inc (NYSE:ATNM) Surges on Analyst Upgrade Amidst Radiopharma Sector Momentum
22 Mar 24
News, Press Releases
Actinium Pharmaceuticals Inc (ATNM) Targets Breakthrough in Cancer Therapy: Proprietary Production of Vital Isotope Sparks Industry Buzz and Share Surge
21 Mar 24
Actinium Pharmaceuticals Inc (ATNM) Targets Breakthrough in Cancer Therapy: Proprietary Production of Vital Isotope Sparks Industry Buzz and Share Surge
21 Mar 24
News, Press Releases
Actinium Pharmaceuticals Inc. (ATNM) Leads Breakthroughs in Targeted Radiotherapy with Iomab-B and Strategic Production of Actinium-225
20 Mar 24
News, Press Releases
Actinium Pharmaceuticals (NYSE AMERICAN: ATNM) launches strategic initiative focused on the manufacture of the highly sought after medical isotope Actinium-225 (Ac-225)
14 Mar 24
News, Press Releases
Actinium Pharmaceuticals Launches Actinium-225 Focused Strategic Initiative to Leverage Proprietary Cyclotron Based Manufacturing Technology to Address Growing Market Demand
11 Mar 24
Press Releases
Actinium Highlights Improved Survival with Iomab-B in TP53 Positive Relapsed Refractory Acute Myeloid Leukemia Patients in the SIERRA Trial and Other Presentations at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®
23 Feb 24
Press Releases